MicroRNA-379 acts as a tumor suppressor in non-small cell lung cancer by targeting the IGF-1R-mediated AKT and ERK pathways

Torre, 2015, Global cancer statistics, 2012, CA Cancer J Clin, 65, 87, 10.3322/caac.21262

Chen, 2015, Annual report on status of cancer in China, 2011, Chin J Cancer Res, 27, 2, 10.1186/s40880-015-0001-2

Ramnath, 2013, Treatment of stage III non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines, Chest, 143, eS314, 10.1378/chest.12-2360

Cao, 2016, MicroRNA-7 inhibits cell proliferation, migration and invasion in human non-small cell lung cancer cells by targeting FAK through ERK/MAPK signaling pathway, Oncotarget, 7, 77468, 10.18632/oncotarget.12684

Xu, 2014, The possibility of traditional Chinese Medicine as maintenance therapy for advanced nonsmall cell lung cancer, Evid Based Complement Alternat Med, 2014, 278917, 10.1155/2014/278917

Zarogoulidis, 2013, Treatment of non-small cell lung cancer (NSCLC), J Thorac Dis, 5, S389

Verdecchia, 2007, EUROCARE-4 Working Group: Recent cancer survival in Europe: A 2000–02 period analysis of EUROCARE-4 data, Lancet Oncol, 8, 784, 10.1016/S1470-2045(07)70246-2

2014, Highlights in NSCLC from the 2014 American Society of Clinical Oncology annual meeting, Clin Adv Hematol Oncol, 12, S7

Mountain, 1997, Revisions in the International System for Staging Lung Cancer, Chest, 111, 1710, 10.1378/chest.111.6.1710

Goldstraw, 2011, Non-small-cell lung cancer, Lancet, 378, 1727, 10.1016/S0140-6736(10)62101-0

Rosell, 2013, Genetics and biomarkers in personalisation of lung cancer treatment, Lancet, 382, 720, 10.1016/S0140-6736(13)61715-8

Bartel, 2004, MicroRNAs: Genomics, biogenesis, mechanism, and function, Cell, 116, 281, 10.1016/S0092-8674(04)00045-5

Jiang, 2010, MicroRNA-7 targets IGF1R (insulin-like growth factor 1 receptor) in tongue squamous cell carcinoma cells, Biochem J, 432, 199, 10.1042/BJ20100859

Xiong, 2011, MiR-886-3p regulates cell proliferation and migration, and is dysregulated in familial non-medullary thyroid cancer, PLoS One, 6, e24717, 10.1371/journal.pone.0024717

Ambros, 2004, The functions of animal microRNAs, Nature, 431, 350, 10.1038/nature02871

Kloosterman, 2006, The diverse functions of microRNAs in animal development and disease, Dev Cell, 11, 441, 10.1016/j.devcel.2006.09.009

Broderick, 2011, MicroRNA therapeutics, Gene Ther, 18, 1104, 10.1038/gt.2011.50

Li, 2017, MicroRNA-219-5p represses the proliferation, migration, and invasion of gastric cancer cells by targeting the LRH-1/Wnt/b-catenin signaling pathway, Oncol Res, 25, 617, 10.3727/096504016X14768374457986

Wu, 2017, miR-508-5p acts as an anti-oncogene by targeting MESDC1 in hepatocellular carcinoma, Neoplasma, 64, 40, 10.4149/neo_2017_105

Li, 2017, MiR-141-3p promotes prostate cancer cell proliferation through inhibiting kruppel-like factor-9 expression, Biochem Biophys Res Commun, 482, 1381, 10.1016/j.bbrc.2016.12.045

Wu, 2016, Tumor-suppressing effects of microRNA-429 in human renal cell carcinoma via the downregulation of Sp1, Oncol Lett, 12, 2906, 10.3892/ol.2016.4953

Ma, 2017, MicroRNA-302a targets GAB2 to suppress cell proliferation, migration and invasion of glioma, Oncol Rep, 37, 1159, 10.3892/or.2016.5320

Ma, 2016, Up-regulation of miR-328-3p sensitizes non-small cell lung cancer to radiotherapy, Sci Rep, 6, 31651, 10.1038/srep31651

Maugeri-Saccà, 2012, MicroRNAs and prostate cancer: From preclinical research to translational oncology, Cancer J, 18, 253, 10.1097/PPO.0b013e318258b5b6

Khan, 2013, miR-379 regulates cyclin B1 expression and is decreased in breast cancer, PLoS One, 8, e68753, 10.1371/journal.pone.0068753

Gururajan, 2014, miR-154* and miR-379 in the DLK1-DIO3 microRNA mega-cluster regulate epithelial to mesenchymal transition and bone metastasis of prostate cancer, Clin Cancer Res, 20, 6559, 10.1158/1078-0432.CCR-14-1784

Chen, 2016, MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma, Cancer Lett, 375, 73, 10.1016/j.canlet.2016.02.043

Li, 2017, MicroRNA-379 suppresses osteosarcoma progression by targeting PDK1, J Cell Mol Med, 21, 315, 10.1111/jcmm.12966

Hao, 2017, Suppression of EIF4G2 by miR-379 potentiates the cisplatin chemosensitivity in nonsmall cell lung cancer cells, FEBS Lett, 591, 636, 10.1002/1873-3468.12566

Livak, 2001, Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method, Methods, 25, 402, 10.1006/meth.2001.1262

Yin, 2009, Insulin-like growth factor-1 receptor-targeted therapy for non-small cell lung cancer: A mini review, Am J Transl Res, 1, 101

Qian, 2007, Suppression of type 1 insulin-like growth factor receptor expression by small interfering RNA inhibits A549 human lung cancer cell invasion in vitro and metastasis in xenograft nude mice, Acta Biochim Biophys Sin (Shanghai), 39, 137, 10.1111/j.1745-7270.2007.00257.x

Kim, 2012, Expressions of insulin-like growth factor receptor-1 and insulin-like growth factor binding protein 3 in advanced non-small-cell lung cancer, Clin Lung Cancer, 13, 385, 10.1016/j.cllc.2011.11.009

Cao, 2015, Combinational therapy enhances the effects of anti-IGF-1R mAb Figitumumab to target small cell lung cancer, PLoS One, 10, e0135844, 10.1371/journal.pone.0135844

Zhang, 2015, MicroRNA-133a functions as a tumor suppressor by targeting IGF-1R in hepatocellular carcinoma, Tumour Biol, 36, 9779, 10.1007/s13277-015-3749-8

Osaki, 2013, MAPKs and signal transduction in the control of gastrointestinal epithelial cell proliferation and differentiation, Int J Mol Sci, 14, 10143, 10.3390/ijms140510143

Cao, 2007, Insulin-like growth factor-I induces cyclooxygenase-2 expression via PI3K, MAPK and PKC signaling pathways in human ovarian cancer cells, Cell Signal, 19, 1542, 10.1016/j.cellsig.2007.01.028

Li, 2017, miR-592 functions as a tumor suppressor in human non-small cell lung cancer by targeting SOX9, Oncol Rep, 37, 297, 10.3892/or.2016.5275

Li, 2016, MiR-150 promotes cellular metastasis in non-small cell lung cancer by targeting FOXO4, Sci Rep, 6, 39001, 10.1038/srep39001

Pei, 2016, MicroRNA-185-5p modulates chemosensitivity of human non-small cell lung cancer to cisplatin via targeting ABCC1, Eur Rev Med Pharmacol Sci, 20, 4697

Esquela-Kerscher, 2006, Oncomirs - microRNAs with a role in cancer, Nat Rev Cancer, 6, 259, 10.1038/nrc1840

Yamamoto, 2014, MiR-379/411 cluster regulates IL-18 and contributes to drug resistance in malignant pleural mesothelioma, Oncol Rep, 32, 2365, 10.3892/or.2014.3481

Hu, 2014, Down-regulation of miRNA-452 is associated with adriamycin-resistance in breast cancer cells, Asian Pac J Cancer Prev, 15, 5137, 10.7314/APJCP.2014.15.13.5137

Li, 2013, The insulin-like growth factor-I receptor inhibitor picropodophyllin-induced selective apoptosis of hepatocellular carcinoma cell through a caspase-dependent mitochondrial pathway, Oncol Res, 21, 103

Wang, 2012, Increased expression of insulin-like growth factor-1 receptor is correlated with tumor metastasis and prognosis in patients with osteosarcoma, J Surg Oncol, 105, 235, 10.1002/jso.22077

Ma, 2012, Induction of IGF-1R expression by EGR-1 facilitates the growth of prostate cancer cells, Cancer Lett, 317, 150, 10.1016/j.canlet.2011.11.021

Sichani, 2010, Prognostic value of insulin- like growth factor-I receptor expression in renal cell carcinoma, Saudi J Kidney Dis Transpl, 21, 69

Gryko, 2014, Expression of insulin-like growth factor receptor type 1 correlate with lymphatic metastases in human gastric cancer, Pol J Pathol, 65, 135, 10.5114/pjp.2014.42678

Xie, 2004, Expression of IGF-I and IGF-IR in bladder cancer, Chin J Cancer, 23, 707

Pollak, 2004, Insulin-like growth factors and neoplasia, Novartis Found Symp, 262, 84, 10.1002/0470869976.ch6

Werner, 1996, The role of the insulin-like growth factor system in human cancer, Adv Cancer Res, 68, 183, 10.1016/S0065-230X(08)60354-1

Pollak, 2012, The insulin and insulin-like growth factor receptor family in neoplasia: An update, Nat Rev Cancer, 12, 159, 10.1038/nrc3215

King, 2014, Can we unlock the potential of IGF-1R inhibition in cancer therapy?, Cancer Treat Rev, 40, 1096, 10.1016/j.ctrv.2014.07.004

Tsuta, 2013, Insulin-like growth factor-1 receptor protein expression and gene copy number alterations in non-small cell lung carcinomas, Hum Pathol, 44, 975, 10.1016/j.humpath.2012.09.002

Zhang, 2014, IGF-1R and Bmi-1 expressions in lung adenocarcinoma and their clinicopathologic and prognostic significance, Tumour Biol, 35, 739, 10.1007/s13277-013-1100-9

Wei, 2015, Effects of insulin-like growth factor 1 receptor and its inhibitor AG1024 on the progress of lung cancer, J Huazhong Univ Sci Technolog Med Sci, 35, 834, 10.1007/s11596-015-1515-1